Evidence map›Paper›PMID 38292608›Full record

ArticleACS central science2024

Inserting "OFF-to-ON" BODIPY Tags into Cytokines: A Fluorogenic Interleukin IL-33 for Real-Time Imaging of Immune Cells.

Abigail E Reese, Fabio de Moliner, Lorena Mendive-Tapia, Sam Benson, Erkin Kuru, Thomas Bridge, Josh Richards, Jonathan Rittichier, Takanori Kitamura, Amit Sachdeva and 2 more

Open access · diamondAbstract read
In one paragraph

Article in ACS central science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Abigail E ReeseCentre for Inflammation Research, The University of Edinburgh, EH16 4UU Edinburgh, United Kingdom.
Fabio de MolinerCentre for Inflammation Research, The University of Edinburgh, EH16 4UU Edinburgh, United Kingdom.
Lorena Mendive-TapiaCentre for Inflammation Research, The University of Edinburgh, EH16 4UU Edinburgh, United Kingdom.
Sam BensonCentre for Inflammation Research, The University of Edinburgh, EH16 4UU Edinburgh, United Kingdom.
Erkin KuruDepartment of Genetics, Harvard Medical School, Boston, Massachusetts 02115, United States.
Thomas BridgeSchool of Chemistry, University of East Anglia, Norwich NR4 7TJ, United Kingdom.
Josh RichardsDivision of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee DD1 4HN, United Kingdom.
Jonathan RittichierDepartment of Genetics, Harvard Medical School, Boston, Massachusetts 02115, United States.
Takanori KitamuraCentre for Reproductive Health, The University of Edinburgh, EH16 4UU Edinburgh, United Kingdom.
Amit SachdevaSchool of Chemistry, University of East Anglia, Norwich NR4 7TJ, United Kingdom.ORCID https://orcid.org/0000-0002-3704-5750
Henry J McSorleyDivision of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee DD1 4HN, United Kingdom.
Marc VendrellCentre for Inflammation Research, The University of Edinburgh, EH16 4UU Edinburgh, United Kingdom.ORCID https://orcid.org/0000-0002-5392-9740
MRC Centre for Regenerative Medicine · GBHarvard University · USUniversity of Dundee · GBUniversity of East Anglia · GBMRC Centre for Reproductive Health · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The essential functions that cytokine/immune cell interactions play in tissue homeostasis and during disease have prompted the molecular design of targeted fluorophores to monitor their activity in real time. Whereas activatable probes for imaging immune-related enzymes are common, many immunological functions are mediated by binding events between cytokines and their cognate receptors that are hard to monitor by live-cell imaging. A prime example is interleukin-33 (IL-33), a key cytokine in innate and adaptive immunity, whose interaction with the ST2 cell-surface receptor results in downstream signaling and activation of NF-κB and AP-1 pathways. In the present work, we have designed a chemical platform to site-specifically introduce OFF-to-ON BODIPY fluorophores into full cytokine proteins and generate the first nativelike fluorescent analogues of IL-33. Among different incorporation strategies, chemical aminoacylation followed by bioorthogonal derivatization led to the best labeling results. Importantly, the BODIPY-labeled IL-33 derivatives-unlike IL-33-GFP constructs-exhibited ST2-specific binding and downstream bioactivity profiles comparable to those of the wild-type interleukin. Real-time fluorescence microscopy assays under no wash conditions confirmed the internalization of IL-33 through ST2 receptors and its intracellular trafficking through the endosomal pathway. We envision that the modularity and versatility of our BODIPY labeling platform will facilitate the synthesis of minimally tagged fluorogenic cytokines as the next generation of imaging reagents for real-time visualization of signaling events in live immune cells.

Identifiers

PMID38292608
PMCPMC10823590
OpenAlexW4390034314

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.